Our Innosuisse project with Dr. Markus Rimann and the ZHAW 3D Gewebe und Biofabrikation group was featured in the latest ZHAW Transfer magazine (1/26), highlighting our work combining bioprinted skeletal muscle and fat tissue in a single system to study metabolic diseases like diabetes and obesity, advancing 3R aligned alternatives to animal testing.

Presented "3R Innovations: Advancing Human Relevant Bone Tissue Models Through Biomaterials, Bioprinting, and Organ on Chip Technologies" to a visiting Axiom Space delegation, showcasing how our bone tissue models and bioprinting platforms can support space biotech research and reduce reliance on animal testing.

Anirveda Engineering was selected among 20 winning startups in the Pfizer INDovation Programme (IP Support Edition) 2025 to 2026, a flagship initiative by FITT IIT Delhi, Pfizer India, and Social Alpha, gaining access to end to end IP consultation, commercialisation support, and a curated network of investors and industry mentors to help scale our healthcare innovation.

Gave an interview for National Research Programme 79 "Advancing 3R", sharing insights on how our bioprinted tissue models are helping reduce animal testing and advance disease modeling, and discussing the broader impact of this work for the 3R community in Switzerland.

Presented our bioprinted tissue model work at the 3R Fair 2026 in Fribourg (NRP 79, April 15), hosting a table to share how engineered living tissues can advance disease modeling and reduce reliance on animal testing.



RennoWaste Private Limited has been selected for the NIDHI I TBI grant by INurture Incubation Foundation at ABES Engineering College, Ghaziabad, supporting our work in agricultural waste valorization, including biorefinery technologies, as we scale toward commercial deployment in India.

Our 3DScreen project has been awarded an Innosuisse Initial Coaching Grant, providing structured coaching and guidance to strengthen our high throughput disease modeling platform as we prepare for a full Innosuisse innovation project application.

Prof Tim Woodfield visits to discuss how bioprinting and biomaterials are advancing tissue engineering for regenerative and precision medicine.

